Eterna Therapeutics Inc (ERNA) — Cash Flow Quality Index

Latest as of September 2018: 4.30x

Eterna Therapeutics Inc (ERNA) has a Cash Flow Quality Index of 4.30x as of September 2018. Operating cash flow of $954.00 Million exceeds net income of $222.00 Million, indicating high earnings quality where cash backs reported profits. Explore Eterna Therapeutics Inc (ERNA) investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

4.30x

Operating CF / Net Income

Operating Cash Flow

$954.00 Million

USD

Net Income

$222.00 Million

USD

Data as of

Sep 2018

Most recent filing

Annual Cash Flow Quality Index for Eterna Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Eterna Therapeutics Inc. For live market cap and the full company financial profile, see Eterna Therapeutics Inc market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.